Skip to navigation Skip to main content

LARTRUVO (olaratumab) for Soft Tissue Sarcoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for LARTRUVO (olaratumab), indicated for soft tissue sarcoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 8: Use in Specific Populations
Slide 11: Clinical Pharmacology
Slide 15: Warnings and Precautions
Slide 19: Clinical Safety and Efficacy
Slide 26: Drug Storage and Supply
Slide 29: References

Topics:

Drug Showcase Sarcoma
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More